Eczema

Typical, mild dermatitis
ICD-10 | L20-L30
ICD-9 | 692
OMIM | 603165
DiseasesDB | 4113
MedlinePlus | 000853

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Lixia Ellis, M.D., Associate Editor(s)-in-Chief:  Edzel Lorraine Co, DMD, MD[2]

Synonyms and keywords: Atopic dermatitis; Besnier prurigo; Neurodermatitis, atopic; Eczema, atopic

Eczema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eczema from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Social Impact

Future or Investigational Therapies

Case Studies

Case #1

Eczema On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eczema

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eczema

CDC on Eczema

Eczema in the news

Blogs on Eczema

Directions to Hospitals Treating Eczema

Risk calculators and risk factors for Eczema

## Overview

[edit | edit source]

## Historical Perspective

[edit | edit source]

## Classification

[edit | edit source]

## Pathophysiology

[edit | edit source]

## Causes

[edit | edit source]

## Differentiating Eczema from other Diseases

[edit | edit source]

## Epidemiology and Demographics

[edit | edit source]

## Risk Factors

[edit | edit source]

## Screening

[edit | edit source]

## Natural History, Complications, and Prognosis

[edit | edit source]

## Diagnosis

[edit | edit source]

History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies

## Treatment

[edit | edit source]

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Social Impact | Future or Investigational Therapies

## Case Studies

[edit | edit source]

Case #1

## External links

[edit | edit source]

* MedlinePlus: Dermatitis
* National Eczema Society (UK)
* National Eczema Association

* v
* t
* e

Diseases of the skin and subcutaneous tissue (integumentary system) (L, 680-709)

Infections|

Template:Navbox subgroup

Bullous disorders|

acantholysis (Pemphigus, Transient acantholytic dermatosis) * Pemphigoid (Bullous, Cicatricial, Gestational) * Dermatitis herpetiformis

Inflammatory|

Template:Navbox subgroup

Radiation-related disorders|

Sunburn * actinic rays (Actinic keratosis, Actinic cheilitis) * Polymorphous light eruption (Acne aestivalis) * Radiodermatitis * Erythema ab igne

Pigmentation disorder|

hypopigmentation (Albinism, Vitiligo) * hyperpigmentation (Melasma, Freckle, Café au lait spot, Lentigo/Liver spot, Acanthosis nigricans, Acral acanthotic anomaly)

Other skin|

keratosis/hyperkeratosis (Seborrheic keratosis, Callus) * other epidermal thickening (Ichthyosis acquisita, Palmoplantar keratoderma)

skin ulcer (Pyoderma gangrenosum, Bedsore)

Cutaneous Markers of Internal Malignancy (Florid cutaneous papillomatosis, acanthosis nigricans, sign of Leser-Trelat)

atrophic (Lichen sclerosus, Acrodermatitis chronica atrophicans)

necrobiosis (Granuloma annulare, Necrobiosis lipoidica) * other granuloma (Granuloma faciale, Pyogenic granuloma)

cutaneous vasculitis (Livedoid vasculitis, Erythema elevatum diutinum)

Connective tissues|

collagen disease: Keloid
localized connective tissue disorders: Lupus erythematosus (Discoid lupus erythematosus, Subacute cutaneous lupus erythematosus) * Scleroderma/Morphea * Linear scleroderma * Calcinosis cutis * Sclerodactyly * Ainhum

see also congenital, neoplasia

ca:Èczema cs:ekzém de:Ekzem eo:Ekzemo io:Ekzemo it:Eczema he:גרב (מחלה) nl:Eczeem sv:Eksem uk:Екзема

Template:WikiDoc Sources
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template